Methylation-associated silencing of TU3A in human cancers

Yasuo Awakura1, Eijiro Nakamura, Noriyuki Ito

  • 1Department of Urology, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.

Insights

The tumor suppressor gene TU3A is epigenetically silenced by promoter hypermethylation in renal cell carcinoma (RCC), correlating with advanced stages and poor survival. This methylation was also observed in other cancers, suggesting a broader role in tumorigenesis.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • TU3A, a candidate tumor suppressor gene, shows down-regulated expression in various cancers, including renal cell carcinoma (RCC).
  • The mechanisms underlying TU3A inactivation, particularly in RCC, remained largely unexplored prior to this study.

Purpose of the Study:

  • To investigate the expression and promoter CpG island methylation of TU3A in RCC.
  • To determine the association between TU3A hypermethylation and clinicopathological features and survival in RCC patients.
  • To explore TU3A methylation in other cancer types.

Main Methods:

  • Analysis of TU3A mRNA expression in RCC cell lines.
  • Bisulfite sequencing and 5-aza-2'-deoxycytidine/trichostatin A treatment to assess promoter methylation in RCC cell lines.
  • Combined bisulfite restriction analysis (COBRA) to evaluate TU3A methylation in primary RCC and normal kidney tissues.
  • Correlation analysis between TU3A methylation status and clinicopathological data, including tumor stage and patient survival.
  • Examination of TU3A promoter methylation in other cancer cell lines and primary tumors.

Main Results:

  • TU3A mRNA expression was low or absent in examined RCC cell lines.
  • TU3A expression inversely correlated with promoter hypermethylation in RCC cell lines.
  • Hypermethylation of the TU3A promoter was detected in 41.5% of primary RCCs, significantly higher than in normal kidney tissues.
  • TU3A hypermethylation was significantly associated with advanced tumor stage (T stage, N stage, M stage) and poorer disease-specific survival in RCC patients.
  • Promoter hypermethylation of TU3A was also observed in bladder and testis cancer cell lines and primary tumors.

Conclusions:

  • Epigenetic inactivation of TU3A through promoter hypermethylation is a mechanism contributing to RCC development.
  • TU3A hypermethylation serves as a potential biomarker for advanced RCC and poor prognosis.
  • The findings suggest that TU3A epigenetic silencing may play a role in the pathogenesis of multiple human cancers.

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...